|
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
1 |
[GO] |
2024―Dez―16 |
Consequences of coronavirus infection: Hemorheological disorders and possibilities for correction |
Margarita V. Kruchinina, Andrei A. Gromov, Irina I. Logvinenko, Elina V. Kruchinina |
2 |
[GO] |
2024―Mai―27 |
Facial nerve neuropathies after a new coronavirus infection: a clinical observation |
Nadezhda V. Amosova, Stanislav S. Kucherenko, Tatiana M. Alekseeva, Viacheslav A. Ratnikov |
3 |
[GO] |
2024―Mrz―12 |
Development of polyresistance in microorganisms during antibiotic therapy in a multidisciplinary hospital during a pandemic COVID-19 |
Nikolay B. Esaulenko, Olga V. Tkachenko, Sergey P. Kazakov, Denis V. Davydov, Andrey A. Zaytsev, Sergey A. Chernov |
4 |
[GO] |
2024―Mrz―06 |
Changes in the electrical and viscoelastic parameters of erythrocytes in patients with manifestations of metabolic syndrome, COVID-19 convalescents, when exposed to citicoline in an in vitro experiment |
Margarita V. Kruchinina, Andrei A. Gromov, Elina V. Kruchinina, Yulia A. Shishakina |
5 |
[GO] |
2023―Okt―14 |
Monoclonal antibody therapy for COVID-19 during pregnancy |
Diana I. Abdulganieva, Ekaterina V. Dyakova, Era V. Ivanova, Nailya G. Shamsutdinova, Asiya R. Yangurazova, Nigina A. Nigmatullina, Ildar F. Fatkullin |
6 |
[GO] |
2023―Okt―14 |
Community-acquired pneumonia: antibiotic therapy approach after the COVID-19 pandemic. A review |
Andrey A. Zaytsev, Igor A. Guchev |
7 |
[GO] |
2023―Okt―14 |
Features of clinical manifestations and diagnosis of comorbidity of disseminated pulmonary tuberculosis, coronavirus, pneumocystis and pneumococcal pneumonia in patients with late stages of HIV infection with immunodeficiency |
Vladimir Y. Mishin, Anastasiia V. Mishina, Dmitry A. Lezhnev, Aleksandr L. Sobkin, Ivan V. Shashenkov |
8 |
[GO] |
2023―Aug―10 |
Difficulties in differential diagnosis of carbohydrate metabolism disorders in patients with coronavirus infection in real clinical practice. Case report |
Tatyana N. Markova, Mukhamed S. Stas, Valentina V. Chibisova, Anastasia A. Anchutina |
9 |
[GO] |
2023―Jul―30 |
Decreased liver density as a potential predictor of severe COVID-19: a retrospective cohort study |
Yuliya F. Shumskaya, Dina A. Akhmedzyanova, Marina G. Mnatsakanyan |
10 |
[GO] |
2023―Jul―18 |
Impact of COVID-19 on the occurrence and exacerbation of cutaneous forms of lupus erythematosus: A review |
Eleonora S. Mikheeva, Iuliia M. Golubeva, Ekaterina E. Radionova, Olga V. Zhukova, Irina M. Korsunskaya |
11 |
[GO] |
2023―Jun―07 |
COVID-19 and cochleovestibular disorders: A review |
Andrey Yu. Ovchinnikov, Nina A. Miroshnichenko, Kristina V. Savranskaya, Andrey A. Zaitsev |
12 |
[GO] |
2023―Jun―07 |
Immunomodulating agent Galavit for the prevention of frequent acute respiratory viral infections after COVID-19: A review |
Aleksandra G. Rosatkevich |
13 |
[GO] |
2023―Jun―07 |
Сhitotriosidase activity in prediction of poor prognosis in COVID-19 hospitalized patients |
Ekaterina S. Schelkanovtseva, Olga Iu. Mironova, Kirill A. Solovev, Elizaveta A. Berestova, Alexander A. Balakhonov, Ilya O. Nagornov, Victor V. Fomin, Alexandr S. Panferov |
14 |
[GO] |
2023―Jun―07 |
A clinical case of a patient with an anomaly in the development of the inner ear and refractory stimulation of the facial nerve after a coronavirus infection and meningitis |
Vladislav E. Kuzovkov, Sergey V. Levin, Andrei S. Lilenko, Serafima B. Sugarova, Viktoriia A. Tanaschishina, Iulia S. Korneva |
15 |
[GO] |
2023―Mai―15 |
Coagulopathy in cardiac surgery in the context of the COVID-19 pandemic: A review |
Anna V. Basanets, Akmal Z. Rakhimov, Rustam M. Ibrahimov, Elmira U. Asymbekova, Elvina F. Tugeeva, Yuri I. Buziashvili |
16 |
[GO] |
2022―Dez―20 |
Voice changes during the COVID-19 pandemic: A review |
Elena Iu. Radtsig, Anastasiia D. Egina |
17 |
[GO] |
2022―Dez―20 |
Repurposed antimicrobial and antiviral drugs for COVID-19 treatment: safety and side effects in real clinical practice (scientific review) |
Marina V. Leonova |
18 |
[GO] |
2022―Dez―20 |
Clinic and diagnosis and comorbidity of respiratory tuberculosis and viral pneumonia caused by <i>Herpes simplex virus, Cytomegalovirus Human</i> and SARS-CoV-2 in patients with late-stage HIV infection with immunodeficiency |
Vladimir Yu. Mishin, Anastasiia V. Mishina, Dmitry A. Lezhnev, Aleksandr L. Sobkin, Ivan V. Shashenkov |
19 |
[GO] |
2022―Nov―08 |
Changes in the organs and tissues of the oral cavity in the new coronavirus infection (COVID-19): A review |
Dmitry I. Trukhan, Anatoly F. Sulimov, Larissa Yu. Trukhan |
20 |
[GO] |
2022―Nov―08 |
Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection |
Iana Yu. Feklina, Marina G. Mnatsakanyan, Alexander P. Pogromov, Olga V. Tashchyаn |
21 |
[GO] |
2022―Nov―08 |
Jaundice as an atypical manifestation of the new coronavirus infection. Case report |
Irina M. Pichugina, Irina M. Ogoltsova |
22 |
[GO] |
2022―Mai―19 |
Ongoing symptomatic COVID-19 - practical advice: A review |
Andrei A. Zaitsev, Igor' V. Leshchenko |
23 |
[GO] |
2022―Mai―19 |
The effect of a new coronavirus infection (COVID-19) on clinical and radiological manifestations in patients with comorbidity of respiratory tuberculosis, HIV-infection and opportunistic lung diseases: prospective study design |
Vladimir Yu. Mishin, Anastasiia V. Mishina, Dmitriy A. Lezhnev, Aleksandr L. Sobkin, Nаtalya V. Sergeeva, Aleksandr S. Kononets, Irina Yu. Babaeva |
24 |
[GO] |
2022―Mai―19 |
Therapeutic possibilities of rehabilitation of patients who have undergone COVID-19 with residual changes in the lungs: A review |
Galina L. Ignatova, Vladimir N. Antonov |
25 |
[GO] |
2022―Feb―08 |
Possibilities for correcting diffuse alopecia associated with prior coronavirus infection (COVID-19) |
Natalia V. Shperling, Maksim I. Shperling, Irina I. Gnatiuk |
26 |
[GO] |
2022―Feb―08 |
COVID-19: long-term health impacts |
Karine R. Badalyan, Ella Iu. Solovyeva |
27 |
[GO] |
2022―Jan―24 |
Androgenetic alopecia and coronavirus infection |
Olga O. Melnichenko, Luiza R. Sakaniya, Anastas L. Piruzyan, Irina M. Korsunskaya |
28 |
[GO] |
2022―Jan―21 |
Evaluation of laboratory effectiveness of clopidogrel after elective endovascular procedures in patients with the history of the new coronavirus infection (COVID-19) |
Natalia V. Kuchkina, Nino V. Tsereteli, Irina E. Chernysheva, Elena I. Vorobyeva, Irina V. Zubkova, Sergey P. Semitko, David G. Iosseliani, Viktor V. Fomin |
29 |
[GO] |
2022―Jan―21 |
The use of renin-angiotensin system blockers in patients with COVID-19 |
Anton V. Rodionov |
30 |
[GO] |
2022―Jan―21 |
Sleep disorders in patients with COVID-19 |
Marina A. Samushiya, Natalia V. Mironova, Mikhail G. Poluektov |
31 |
[GO] |
2022―Jan―21 |
Myocarditis: diagnosis and treatment in a period of pandemic |
Olga V. Blagova, Evgenyia A. Kogan |
32 |
[GO] |
2021―Okt―11 |
Extrapulmonary tuberculosis during the COVID-19 pandemic: features of detection and course |
Ekaterina V. Kulchavenia, Ekaterina V. Kulchavenia |
33 |
[GO] |
2021―Sep―27 |
Clinical observation of the course of new coronavirus infection in a patient with subacute form of hypersensitive pneumonitis |
Galina M. Kuklina, Aminat Z. Akhmedova, Natalia N. Makariants |
34 |
[GO] |
2021―Sep―27 |
A study of the potential of medicinalplant extracts in suppression of SARS-CoV-2 replication: a pilot study* |
Michela Luisa De Pellegrin, Anette Rohrhofer, Philipp Schuster, Barbara Schmidt, Barbara Schmidt, Philipp Peterburs, Andre Gessner, Andre Gessner |
35 |
[GO] |
2021―Sep―24 |
Injury of vascular endothelium and erythrocytes in COVID-19 patients |
Liudmila I. Buryachkovskaya, Arthur M. Melkumyants, Nikita V. Lomakin, Olga A. Antonova, Vladimir V. Ermiskin |
36 |
[GO] |
2021―Jul―05 |
Long COVID-19 |
Yulia G. Belotserkovskaya, Anna G. Romanovskikh, Igor P. Smirnov, Alexander I. Sinopalnikov |
37 |
[GO] |
2021―Jul―05 |
COVID-19 and community-acquired pneumonia |
Alexander I. Sinopalnikov |
38 |
[GO] |
2021―Jul―05 |
Description of COVID-19 infection course in a patient with multiple comorbidity: hairy cell leukemia, chronic generalized sarcoidosis and deep vein thrombosis in the lower extremities. Case report |
Galina M. Kuklina, Natalia N. Makar'iants |
39 |
[GO] |
2021―Jul―05 |
The actuality of preventing influenza and pneumococcal infection during the ongoing COVID-19 pandemic |
Galina L. Ignatova, Vladimir N. Antonov |
40 |
[GO] |
2021―Apr―16 |
Kidneys and covid-19 |
|
41 |
[GO] |
2021―Apr―16 |
Hemostasis disorders, thrombosis, antiphospholipid antibodies in patients with covid-19 |
Tatiana M. Reshetnyak, Tatiana M. Reshetnyak, Fariza A. Chel'dieva, Fariza A. Chel'dieva, Aleksandr M. Lila, Aleksandr M. Lila, Evgenii L. Nasonov, Evgenii L. Nasonov |
42 |
[GO] |
2021―Apr―16 |
Features of the management of patients with atrial fibrillation during the covid-19 pandemic: current questions and possible answers |
Dmitry A. Napalkov, Anastasiya A. Sokolova, Alena I. Skripka |
43 |
[GO] |
2021―Apr―16 |
Acute ST-segment elevation myocardial infarction in covid-19 patients: a single hospital experience |
Vakhtang I. Safaryan, Kirill A. Savostyanov, Kirill A. Savostyanov, Dmitry S. Sizgunov, Artur Z. Sargsyan, Petr A. Birukov |
44 |
[GO] |
2021―Feb―15 |
Overweight, metabolic syndrome and the course of COVID-19 |
|
45 |
[GO] |
2021―Feb―15 |
Assessment of the duration of QT interval in patients with COVID-19 during treatment with hydroxychloroquine and azithromycin |
Filipp A. Orlov, Filipp A. Orlov, Andrei A. Zaitsev, Andrei A. Zaitsev, Gleb E. Kubenskii, Tatiana N. Pantiukhova |
46 |
[GO] |
2021―Feb―15 |
Сardiotoxicity of chloroquine and hydroxychloroquine in the treatment of COVID-19 infection |
Marina V. Leonova |
47 |
[GO] |
2021―Feb―15 |
Nonsteroidal anti-inflammatory drugs and ibuprofen for COVID-19: a systematic review |
Marina V. Leonova |
48 |
[GO] |
2021―Feb―15 |
Сlinical case of successful use of non-invasive ventilation in a patient with a new coronavirus infection |
Aleksandr Yu. Litvin, Aleksandr Yu. Litvin, Evgeniia M. Elfimova, Oksana O. Mikhailova, Tatiana A. Alekseeva, Olga A. Sivakova, Nikolai M. Danilov, Dmitrii V. Pevzner, Lavrentii O. Dulaev, Ilia T. Zyuryaev, Svetlana A. Gaman |
49 |
[GO] |
2020―Dez―15 |
Favipiravir as a potential countermeasure for COVID-19 |
Marina V. Leonova |
50 |
[GO] |
2020―Dez―15 |
Change in anti-SARS-CoV-2 IgG antibodies (COVID-19) among the population of the Russian Federation regions and in convalescents in dynamics |
Svetlana V. Smetanina, Andrej N. Isaev, Yuliya O. Isaeva, Elena A. Nurmukhametova, Natalya P. Blokhina, Nikolaj A. Nikolaev, Anton V. Ershov, Anton V. Ershov |
51 |
[GO] |
2020―Dez―15 |
Algorithms for the management of patients with a new coronavirus COVID-19 infection in a hospital. Guidelines |
Andrei A. Zaitsev, Sergei A. Chernov, Valerii V. Stets, Mikhail B. Patsenko, Oleg I. Kudriashov, Vladimir A. Chernetsov, Evgenii V. Kriukov |
52 |
[GO] |
2020―Dez―15 |
Changes in markers of hematological, biochemical and coagulological blood tests with coronavirus COVID-19 infections |
Rizvan Yu. Abdullaev, Oksana G. Komissarova, Oksana G. Komissarova |
53 |
[GO] |
2020―Dez―15 |
Antibacterial therapy for ENT diseases during the COVID-19 pandemic |
Valeriy M. Svistushkin, Galina N. Nikiforova, Polina S. Artamonova |
54 |
[GO] |
2020―Dez―15 |
Patients with pulmonary arterial hypertension in the context of the COVID-19 pandemic |
|
55 |
[GO] |
2020―Sep―09 |
Skin manifestations of covid-19 infection and peculiarities of dermatologic care of patients in the pandemic period |
Uladzimir P. Adaskevich |
56 |
[GO] |
2020―Jul―14 |
Cardiovascular pathology and covid-19: briefly on the main |
Sergei V. Nedogoda |
57 |
[GO] |
2020―Jul―14 |
Sports medicine and sports population under conditions of the coronavirus epidemic |
Viktoriia A. Badtieva, Viktoriia A. Badtieva, Aleksandr S. Sharykin, Aleksandr S. Sharykin, Irina E. Zelenkova, Irina E. Zelenkova |
58 |
[GO] |
2020―Jun―26 |
What is the danger of the covid-19 epidemic for patients with diabetes? |
|
59 |
[GO] |
2020―Apr―17 |
Covid-19: a respiratory infection caused by new coronavirus: new data on epidemiology, clinical course, and patients management |
Yu. G. Belotserkovskaia, A. G. Romanovskikh, I. P. Smirnov |